"The story is on track, and I think you buy the stock," Jim Cramer said during Wednesday's Morning Meeting .
Since its 2023 lows on July 13, Humana stock rallied more than 23% compared with a roughly 7% slide in the S & P 500 over the same stretch.
Management's initial commentary on 2024 earnings and Medicare Advantage membership growth — discussed in more detail below — may also have left investors wanting.
Humana also expects EPS growth in 2024 to fall on the lower end of its historical long-range 11%-to-15% target.
Capital allocation Humana still expects to buy back about $1.5 billion worth of stock in 2023, finance chief Diamond said on the earnings call.
Persons:
—, Jim Cramer, they've, UnitedHealth, Humana, Susan Diamond, Diamond, Bruce Broussard, Jim Rechtin, Broussard, Jim Cramer's, Jim
Organizations:
Medicare, Revenue, Humana, UnitedHealth, CNBC, Inc